Connection

Sakamuri Reddy to Mice

Back to Details
This is a "connection" page, showing publications Sakamuri Reddy has written about Mice.
Sakamuri Reddy
Connection Strength
0.926
Mice
  1. Inhibition of NFAM1 suppresses phospho-SAPK/JNK signaling during osteoclast differentiation and bone resorption. J Cell Biochem. 2021 10; 122(10):1534-1543.
    View in: PubMed
    Score: 0.082
  2. Proteasome inhibition suppress microgravity elevated RANK signaling during osteoclast differentiation. Cytokine. 2020 01; 125:154821.
    View in: PubMed
    Score: 0.072
  3. Microgravity modulation of syncytin-A expression enhance osteoclast formation. J Cell Biochem. 2018 07; 119(7):5696-5703.
    View in: PubMed
    Score: 0.065
  4. Autoregulation of RANK ligand in oral squamous cell carcinoma tumor cells. J Cell Physiol. 2018 08; 233(8):6125-6134.
    View in: PubMed
    Score: 0.065
  5. NFAM1 signaling enhances osteoclast formation and bone resorption activity in Paget's disease of bone. Bone. 2017 Aug; 101:236-244.
    View in: PubMed
    Score: 0.062
  6. Microgravity Induction of TRAIL Expression in Preosteoclast Cells Enhances Osteoclast Differentiation. Sci Rep. 2016 05 04; 6:25143.
    View in: PubMed
    Score: 0.057
  7. Microgravity control of autophagy modulates osteoclastogenesis. Bone. 2014 Apr; 61:125-31.
    View in: PubMed
    Score: 0.049
  8. Mutant p62P392L stimulation of osteoclast differentiation in Paget's disease of bone. Endocrinology. 2011 Nov; 152(11):4180-9.
    View in: PubMed
    Score: 0.041
  9. Microarray profile of gene expression during osteoclast differentiation in modelled microgravity. J Cell Biochem. 2010 Dec 01; 111(5):1179-87.
    View in: PubMed
    Score: 0.039
  10. Osteoclast inhibitory peptide-1 binding to the Fc gammaRIIB inhibits osteoclast differentiation. Endocrinology. 2010 Sep; 151(9):4389-99.
    View in: PubMed
    Score: 0.038
  11. Role of CXC chemokine ligand 13 in oral squamous cell carcinoma associated osteolysis in athymic mice. Int J Cancer. 2010 May 15; 126(10):2319-29.
    View in: PubMed
    Score: 0.038
  12. Bone loss in survival motor neuron (Smn(-/-) SMN2) genetic mouse model of spinal muscular atrophy. J Pathol. 2009 Sep; 219(1):52-60.
    View in: PubMed
    Score: 0.036
  13. Osteoclast inhibitory peptide-1 (OIP-1) inhibits measles virus nucleocapsid protein stimulated osteoclast formation/activity. J Cell Biochem. 2008 Jul 01; 104(4):1500-8.
    View in: PubMed
    Score: 0.033
  14. Congenital bone fractures in spinal muscular atrophy: functional role for SMN protein in bone remodeling. J Child Neurol. 2007 Aug; 22(8):967-73.
    View in: PubMed
    Score: 0.031
  15. RANK ligand signaling modulates the matrix metalloproteinase-9 gene expression during osteoclast differentiation. Exp Cell Res. 2007 Jan 01; 313(1):168-78.
    View in: PubMed
    Score: 0.030
  16. RANK ligand expression in heat shock factor-2 deficient mouse bone marrow stromal/preosteoblast cells. J Cell Biochem. 2006 Apr 15; 97(6):1362-9.
    View in: PubMed
    Score: 0.029
  17. Functional characterization of human osteoclast inhibitory peptide-1 (OIP-1/hSca) gene promoter. Gene. 2006 Apr 12; 371(1):16-24.
    View in: PubMed
    Score: 0.028
  18. CytokineRegulation and the signaling mechanism of osteoclast inhibitory peptide-1 (OIP-1/hSca) to inhibit osteoclast formation. J Bone Miner Res. 2003 Mar; 18(3):458-65.
    View in: PubMed
    Score: 0.023
  19. Kynurenine Promotes RANKL-Induced Osteoclastogenesis In Vitro by Activating the Aryl Hydrocarbon Receptor Pathway. Int J Mol Sci. 2020 Oct 26; 21(21).
    View in: PubMed
    Score: 0.020
  20. Inhibition of acid ceramidase regulates MHC class II antigen presentation and suppression of autoimmune arthritis. Cytokine. 2020 11; 135:155219.
    View in: PubMed
    Score: 0.019
  21. Fibulin-1 is required for bone formation and Bmp-2-mediated induction of Osterix. Bone. 2014 Dec; 69:30-8.
    View in: PubMed
    Score: 0.013
  22. NIP45 negatively regulates RANK ligand induced osteoclast differentiation. J Cell Biochem. 2012 Apr; 113(4):1274-81.
    View in: PubMed
    Score: 0.011
  23. PIAS3 negatively regulates RANKL-mediated osteoclastogenesis directly in osteoclast precursors and indirectly via osteoblasts. Blood. 2009 Mar 05; 113(10):2202-12.
    View in: PubMed
    Score: 0.009
  24. Experimental models of Paget's disease. J Bone Miner Res. 2006 Dec; 21 Suppl 2:P55-7.
    View in: PubMed
    Score: 0.007
  25. Activation of NFAT signal in vivo leads to osteopenia associated with increased osteoclastogenesis and bone-resorbing activity. J Immunol. 2006 Aug 15; 177(4):2384-90.
    View in: PubMed
    Score: 0.007
  26. Cloning and characterization of the annexin II receptor on human marrow stromal cells. J Biol Chem. 2006 Oct 13; 281(41):30542-50.
    View in: PubMed
    Score: 0.007
  27. Expression of measles virus nucleocapsid protein in osteoclasts induces Paget's disease-like bone lesions in mice. J Bone Miner Res. 2006 Mar; 21(3):446-55.
    View in: PubMed
    Score: 0.007
  28. Critical roles of c-Jun signaling in regulation of NFAT family and RANKL-regulated osteoclast differentiation. J Clin Invest. 2004 Aug; 114(4):475-84.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.